Compounds > catechin

catechin and Esophagitis

catechin has been researched along with Esophagitis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Kong, L; Li, X; Meng, X; Wang, Y; Xie, P; Xing, L; Yu, J; Zhang, Y; Zhao, H; Zhu, W1
Chen, G; Jia, L; Li, X; Meng, X; Xing, L; Zhao, H; Zhao, X; Zhu, W1
Kępka, L; Rychter, A1
Li, H; Sun, X; Xie, P; Xing, L; Yu, J; Zhang, X; Zhao, H; Zhu, W1
Chen, X; Li, X; Sun, X; Xie, P; Xing, L; Yu, J; Zhao, H; Zhu, W1

Trials

4 trial(s) available for catechin and Esophagitis

ArticleYear
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer.
    Journal of medicinal food, 2020, Volume: 23, Issue:1

    Topics: Adult; Aged; Catechin; Chemoradiotherapy; China; Esophageal Neoplasms; Esophagitis; Female; Humans; Male; Middle Aged; Prospective Studies; Radiation Injuries

2020
A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 137

    Topics: Acute Disease; Aged; Carcinoma, Non-Small-Cell Lung; Catechin; Chemoradiotherapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage

2019
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 110, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Catechin; Chemoradiotherapy; Cisplatin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage

2014
A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2015, Volume: 114, Issue:3

    Topics: Adult; Aged; Catechin; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Quality of Life; Radiation Injuries

2015

Other Studies

1 other study(ies) available for catechin and Esophagitis

ArticleYear
EGCG, a green tea polyphenol, as one more weapon in the arsenal to fight radiation esophagitis?
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 137

    Topics: Catechin; Esophagitis; Humans; Lung Neoplasms; Prospective Studies; Tea; Weapons

2019